Combination lamivudine and adefovir versus entecavir for the treatment of na? ve chronic hepatitis B patients:A pilot study

科研成果详情

题名	Combination lamivudine and adefovir versus entecavir for the treatment of na? ve chronic hepatitis B patients:A pilot study
作者	Qingwei Du ; Jiguang Ding ; Qingfeng Sun ; Liang Hong ; Fujing Cai ; Qingqing Zhou ; Yanghe Wu ; Rongquan Fu
发表日期	2014-06-13
会议录名称	中华医学会第十三次全国感染病学术会议论文汇编影响因子和分区
语种	英语
原始文献类型	中国会议
摘要	Background The aim of this study was to compare the effect of combination lamivudine(LAM)and adefovir dipivoxil(ADV)versus entecavir(ETV)monotherapy for na?ve HBeAg-positive ehronie hepatitis B(CHB)patients.Material and Methods Fifty enrolled patients with CHB were evenly divided into 2 groups:a group treated with of lamivudine(LAM)(100 mg/day)plus adefovir(ADV)(10 mg/day)combination,and
页码	1
收录类别	CNKI
文献类型	会议论文
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/167957
专题	其他_附属第三医院（瑞安市人民医院）
作者单位	1.Department of Infectious Diseases 2.the Third Affiliated Hospital to Wenzhou Medical College
推荐引用方式 GB/T 7714	Qingwei Du,Jiguang Ding,Qingfeng Sun,et al. Combination lamivudine and adefovir versus entecavir for the treatment of na? ve chronic hepatitis B patients:A pilot study[C],2014:1.